Zydus Lifesciences gets exclusive marketing rights for OncoStem’s prognostic test for breast cancer Breast cancer is the leading cause of cancer in women in India and its risk increases with age. It is… November 16, 2022 15:07 IST
Zydus Lifesciences net profit plunge by 82.6% The company’s Research & Development (R&D) investments for the quarter stood at Rs 253 crore which is 6.1% of revenues. Updated: November 13, 2022 18:58 IST
USFDA approves 2 generic drugs of Zydus Lifesciences According to the company, both drugs will be manufactured at the group’s formulation manufacturing facility in Ahmedabad SEZ. October 17, 2022 14:21 IST
Keki Mistry, Jaspal Bindra, other industry A-listers to share insights at the FE CFO Connect Conclave The FE CFO Connect Conclave 2022 is seeing some of the best minds from the Indian financial world and the… September 18, 2022 10:27 IST
Zydus Lifesciences Q1 consolidated net profit falls to Rs 518 crore However, excluding sales of COVID related products, the business grew 12 per cent year-on-year. August 10, 2022 17:27 IST
Zydus gets USFDA nod for chemotherapy drug The approval granted by the US Food and Drug Administration (USFDA) is for Pemetrexed for injection, in strengths of 100… May 26, 2022 15:32 IST
Zydus Lifesciences gets USFDA nod for generic product The approval granted by the US Food and Drug Administration (USFDA) is for Cyanocobalamin injection in strengths of 1,000 mcg/ml,… April 18, 2022 15:29 IST
FE Pharma Summit to see industry titans swap ideas on steps to counter prickly challenges The two day FE Pharma Summit 2022 is also an attempt to leverage the ability of the Indian pharma stakeholders… Updated: March 23, 2022 15:05 IST
Zydus Lifesciences gets USFDA nod to market generic version of colestipol hydrochloride tablets The approval by the US Food and Drug Administration is for colestipol hydrochloride of 1 mg strength, the company said… Updated: March 14, 2022 12:31 IST
Zydus gets DCGI nod for drug to treat anaemia associated with chronic kidney disease The clinical development programme of Desidustat was one of the largest trials of its kind in India for Anemia in… March 7, 2022 13:11 IST
Cadila Healthcare to be known as Zydus Lifesciences as part of new innovation centric corporate brand identity The company’s new brand identity brings together two hearts in purple and teal colours symbolising its commitment to science and… February 25, 2022 13:37 IST
